Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore"Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth wit...
25 Jul, 2022, 08.36 PM IST
GlaxoSmithKline Pharma Q1 results: Net profit up 9% at Rs 121 croreConsolidated revenue from operations of the company stood at Rs 789.99 crore for the quarter under consideration. It was Rs 648.59 crore fo...
27 Jul, 2021, 12.50 AM IST
GlaxoSmithKline Pharma Q4 results: Reports net profit of Rs 14 crIts consolidated revenue from operations stood at Rs 813.75 crore for the quarter under consideration. It was Rs 775.80 crore a year ago
18 May, 2021, 10.47 PM IST
GlaxoSmithKline Pharma Q1 results: Net profit declines 2.38% to Rs 111 crThe company had posted a net profit of Rs 113.54 crore in the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said...
29 Jul, 2020, 10.24 PM IST
GSK Pharma Q1 net profit up 35% at Rs 113.54 croreStandalone total income of the company also rose to Rs 818.78 crore for the quarter.
22 Jul, 2019, 04.28 PM IST
GlaxoSmithKline Pharma Q2 net profit up 32% at Rs 130 croreThe company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal.
25 Oct, 2017, 08.07 PM IST
CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
07 Mar, 2017, 11.13 PM IST
GSK Pharma Q1 net down 23 per cent at Rs 72.27 croreThe company had posted a net profit of Rs 94.01 crore for the same period year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
28 Jul, 2016, 04.42 PM IST
GlaxoSmithKline Pharma Q3 net profit declines 61% to Rs 45 croreGlaxoSmithKline Pharmaceuticals today reported a 61.24 per cent decline in its net profit at Rs 45.30 crore for the October-December period.
12 Feb, 2015, 07.09 PM IST
GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
10 Mar, 2014, 04.04 PM IST
GSK Pharma shares slump over 8% ahead of closure of open offerShares of GlaxoSmithKline Pharmaceuticals slumped over 8 per cent as the open offer made by its UK-based parent to acquire additional stake...
05 Mar, 2014, 06.05 PM IST
GSK gets FIPB nod to buy 24.33% more in indian armThe Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33%stake, or 2.06 crore, equity shares in GlaxoSmithKline Pharmace...
14 Jan, 2014, 04.00 AM IST
GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
24 Dec, 2013, 04.32 PM IST
- Buy GlaxoSmithKline Pharmaceuticals with a target of 2350: Ashwani Gujral
GlaxoSmithKline Pharmaceuticals Ltd is a ‘BUY’ call with a target of Rs 2350 and a stop loss of Rs 2200.
11 Sep, 2012, 11.06 AM IST
- GlaxoSmithKline net up 18 pc at Rs 136.74 crore
GlaxoSmithKline Pharmaceuticals said its net profit rose by 18.18 per cent to Rs 136.74 crore for the quarter ended December 31, 2011.
16 Feb, 2012, 03.30 PM IST
- GlaxoSmithKline 2010 net profit up 10.37 pc to Rs 560.57 cr
The company's board of director recommended a dividend of Rs 40 per share for the year ended December 31, 2010, in its meeting today.
14 Feb, 2011, 02.49 PM IST